Local fibrinolysis of occluded peripheral arteries;Lokale fibrinolyse peripher arterieller gefassverschlusse

RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren

Volumn 169, Issue 3, 1998, Pages 227-235

  Schwarzenberg, H ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Catheter fibrinolysis; Fibrinolytic agents; Local fibrinolysis; Peripheral occlusive arterial disease; Thromboembolic disorder

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

BLEEDING; DRUG EFFICACY; EMBOLECTOMY; FIBRINOLYSIS; HUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; TREATMENT INDICATION; DRUG CONTRAINDICATION; FIBRINOLYTIC THERAPY; METHODOLOGY; PERIPHERAL VASCULAR DISEASE;

ARTERIAL OCCLUSIVE DISEASES; FIBRINOLYTIC AGENTS; HUMANS; PERIPHERAL VASCULAR DISEASES; THROMBOEMBOLISM; THROMBOLYTIC THERAPY;

EID: 0031710946     PISSN: 09366652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Bachmann F. Fibrinolytic agents. Fibrinolysis 1995; 9: (suppl. 1) 9-15
2. Beathard GA. Mechanical versus pharmacomechanical thrombolysis for the treatment of thrombosed dialysis access grafts. Kidney Int 1994; 45: 1401-1406
3. Bero C, Cardella J, Reddy K, Fox P, Healy D, Jaffe J, Nicholas G. Recombinant tissue plasminogen activator for the treatment of lower extremity peripheral vascular occlusive disease. JVIR 1995; 6: 571-577
4. Bookstein JJ, Valji K, Roberts A. Intrathrombic administration of lytic adjuncts. Radiology 1994; 193: 324
5. Bookstein JJ, Valji K, Roberts A. Pulsed versus conventional thrombolytic infusion techniques. Radiology 1994; 193: 318-320
6. Bookstein JJ, Valji K. Pulse-spray pharmacomechanical thrombolysis. Cardiovasc Intervent Radiol 1992; 15: 228-233
7. Clouse M, Stokes K, Perry L, Wheeler H. Percutaneous intraarterial thrombolysis: analysis of factors affecting outcome. JVIR 1994; 5: 93-100
8. Collen D, Lijnen H. Staphylokinase, a fibrin specific plasminogen activator with therapeutic potential. Blood 1994; 84: 680-686
9. Collen D, Zamarron C, Lijnen H, Hoylaerts M. Activation of plasminogen by pro-urokinase. II. Kinetics. J Biol Chem 1986; 261: 1259-1266
10. Collen D. On the regulation and control of fibrinolysis. Thromb Haemostas 1980; 43: 77-89
11. Decrinis M, Pilger E, Stark G, Lafer M, Obernosterer A, Lammer J. A simplified procedure for intraarterial thrombolysis with tissue-type plasminogen activator in peripheral arterial occlusive disease: primary and long-term results. Eur Heart J 1993; 14: 297-305
12. Diffin D, Kandarpa K. Assessment of peripheral intraarterial thrombolysis versus surgical revascularization in acute lowerlimb ischemia: a review of limbsalvage and mortality statistics. JVIR 1996; 7: 57-63
13. Dotter CT, Roesch J, Seaman A. Selective clot lysis with low-dose streptokinase. Radiology 1974; 111: 31-37
14. Fletcher A, Sherry S, Alkjaersig N, Smyrniotis F, Jick S. The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. J Clin Invest 1959; 38: 1111-1119
15. Fogarty TJ, Cranley JJ, Krause RJ, Strasser E, Hafner C. A method for extraction of arterial emboli and thrombi. Surg Gynecol Obstet 1963; 116: 241-244
16. Froehlich J, Freymann C, Hoppe M, Thiel T, Wagner HJ, Barth KH, Klose K. Local intraarterial thrombolysis: In vitro comparison between automatic and manual pulse-spray infusion. Cardiovasc Intervent Radiol 1996; 19: 423-427
17. Graor RA, Risius B, Lucas FV, Young J, Ruschhaupt W, Beven E, Grossbard E. Thrombolysis with recombinant human tissue - type plasminogen activator in patients with peripheral artery and bypass graft occlusions. Circulation 1986; 74 (suppl.): 15-20
18. Groar RA, Olin J, Bartholomew J, Ruschhaupt W, Young J. Efficacy and safety of intraarterial local infusion of streptokinase, urokinase, or tissue plasminogen activator for peripheral arterial occlusion: a retrospective review. J Vasc Med Biol 1990; 2: 310-315
19. Gruppo Italiano per lo Studio della Sopravivenza nell'lnfarkto Miocardico. GISSI-2.A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction. Lancet 1990; 336: 65-71
20. Hess H, Ingrisch H, Mietaschk A, Rath H. Local low-dose thrombolytic therapy of peripheral arterial occlusions. New Engl J Med 1982; 307: 1626-1630
21. Hess H, Mietschak A, Brückl R. Peripheral arterial occlusion: a 6 year experience with local low dose thrombolytic therapy. Radiology 1987; 163: 753-758
22. Hess H. Lokale Lyse bei peripheren arteriellen Verschlüssen. Herz 1989; 14: 12-21
23. Hoch J, Tullis M, Acher C, Heisey D, Crummy A, McDermott J, Wojtowycz M, Sproat I, Turnipseed W. Thrombolysis versus surgery as the initial management for native artery occlusion: efficacy, safety, and cost. Surgery 1994; 116: 649-657
24. Huettl E, Soulen M. Thrombolysis of lower extremity embolic occlusions: A study of the results of the STAR registry. Radiology 1995; 197: 141-145
25. ISIS-3 Study Group. A randomized comparison of streptokinase versus tissue plasminogen activator versus anistreplase and of aspirin plus heparin versus aspirin alone among 41299 cases of suspected acute myocardial infarction. Lancet 1992; 339: 753-770
26. Janosik J, Bettmann M, Kaul A, Souney P. Therapeutic alternatives for subacute peripheral arterial occlusion: comparison by outcome, length of stay, and hospital charges. Invest Radiol 1991; 26: 921-925
27. Kandarpa K, Chopra PS, Aruny JE, Polak JF, Donaldson M, Whittemore A, Mannick J, Goldhaber S, Meyerovitz M. Intraarterial thrombolysis of lower extremity occlusions: prospective, randomized comparison of forced periodic infusion and conventional slow continous infusion. Radiology 1993; 188: 861-867
28. Kandarpa K, Goldhaber S, Meyerovitz M. Pulse-spray thrombolysis: the "careful analysis". Radiology 1994; 193: 320-324
29. Kandarpa K. Technical determinants of success in catheter directed thrombolysis for peripheral arterial occlusions. JVIR 1995;6(suppl.):55-61
30. Katzen BT, Van Breda A. Low dose streptokinase in the treatment of arterial occlusions. Amer J Roentgenol 1981; 136: 1171-1178
31. Klein P, Roth F, Rieger H, Poppovcenic S.Änderungen systemischer Fibrinolyse- und Gerinnungsparameter während der lokalen Lyse mit Tissue Plasminogen Activator (rt-PA). VASA 1992; 21: 249-252
32. Krause FJ, Endsin O. Lokale Katheterlyse der Femoralarterie: rt-PA versus Urokinase. Fortschr Röntgenstr 1993; 158: 46-48
33. Law M, Gelabert H, Colburn M, Quinones-Baldrich W, Ahn S, Moore W. Continuous postoperative intra-arterial urokinase infusion in the treatment of no reflow following revascularization of the acutely ischemic limb. Ann Vasc Surg 1994; 8: 66-73
34. Leitlinien für radiologische Interventionen. Fibrinolyse und Thrombektomie. Fortschr Röntgenstr 1997; 167: L16-L21
35. Londsdale R, Whitacker S, Berridge D, Earnshaw R, Gregson P, Wenham P, Hopkinson B, Makin G. Peripheral arterial thrombolysis: intermediate term results. Brit J Surg 1993; 80: 592-595
36. Lynch M, Pentecost BL, Littler WA, Stockley RA. Why do patients develop reactions to streptokinase? Clin Exp Immunol 1993; 94: 279-285
37. MacFarlane RG, Pillig J. Fibrinolytic activity of normal urine. Nature 1947; 159: 779-785
38. Martin U, Sponer G, Strein K. Influence of hepatic and renal failure on pharmacokinetic properties of the novel recombinant plasminogen activator BM 06.022 in rats. Drug Metabolism and Disposition 1993; 21: 236-241
39. McNamara TO, Goodwin S, Kandarpa K. Complications of thrombolysis. Semin Intervent Radiol 1994; 11: 134-144
40. McNamara TO. Thrombolysis as an alternative initial therapy for acutely ischemic limb. Semin Vasc Surg 1992; 5: 89-98
41. Meyerovitz MF. Drug variables in thrombolytic therapy. JVIR 1995;6(suppl.):62-65
42. Meyerovitz MF, Goldhaber SZ, Reagan K, Polak JF, Kandarpa K, Grassi CJ, Donovan BC, Bettmann MA, Harrington DP. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial. Radiology 1990, 175: 75-78
43. Ouriel K, Shortell C, Azodo M, Guiterrez O, Marder V. Acute peripheral occlusion: predictors of success in catheter-directed thrombolytic therapy. Radiology 1994; 193: 561-566
44. Ouriel K. Surgery versus thrombolytic therapy in the management of peripheral arterial occlusions. JVIR 1995; 6 (suppl.): 48-54
45. Ouriel K. Randomized comparison of thrombolysis and surgery (TOPAS investigators). JVIR 1995; 6 (suppl.): 83
46. Rauber K, Heidinger K, Kemkes-Matthes B. Coagulation alterations due to local fibrinolytic therapy with recombinant tissue-type plasminogen activator (rt-PA) in patients with peripheral arterial occlusive disease. Cardiovasc Intervent Radiol 1997; 20: 169-173
47. Riede UN. Lokalisierte Kreislaufstörungen. In: Allgemeine und spezielle Pathologie, Hrsg. Riede UN, Wehner H, Thieme Verlag, 1986, S. 360-363
48. Risius B, Groar RA, Geisinger M, Zelch M, Lucas F, Young J. Thrombolytic therapy with recombinant human tissue-type plasminogen activator: A comparison of two doses. Radiology 1987; 164: 465-468
49. Roeren Th, Lachenicht B, Düx M, Hoffmann V, Richter G, Kauffmann G. Therapeutische Effizienz der gepulsten Sprühlyse bei peripheren arteriellen Verschlüssen. Fortschr Röntgenstr 1996; 164:489-495
50. Roeren Th, Düx M. Lokale Fibrinolyse. In: Kauffmann GW, Richter GM (Hrsg.). Gefaßintervention - Thorax, Abdomen, Extremitäten. Springer-Verlag 1994: 68-79
51. Rutherford RP, Flanigan DB, Gupta SK, Johnston KW, Karmody A, Whittemore AD, Baker JD, Ernst CB. Suggested Standards for reports dealing with lower extremity ischemia. J Vasc Surg 1986; 4: 80-94
52. Sandbaek G, Staxrud E, Rosen L, Bay D, Stiris M, Gjølberg T. Factors predicting the outcome of intraarterial thrombolysis in peripheral arterial and graft occlusions. Acta Radiologica 1996; 37:299-304
53. Sandritter W, Thomas C. Gefäße. In: Thomas C (Hrsg.). Histopathologie. Schattauer Verlag: 9.Aufl. 1983, S. 87-91
54. Schoop W, Martin M, Zeitler E. Beseitigung alter Arterienver-schlüsse durch intravenöse Streptokinase-Infusion. Dtsch Med Wschr 1968; 93: 2321-2324
55. Sobel BA, Nachowiak DA, Fry ETA, Bergmann SR, Torr SR. Paradoxical attenuation of fibrinolysis attributable to "plasminogen steal" and its implication for coronary thrombolysis. Cor Art Dis 1990; 1: 111-119
56. Spence L, Hartnell G, Reinking G, McEniff N, Gibbons G, Pomposelli F, Clouse M. Thrombolysis of intrapopliteal bypass grafts: efficacy and underlying angiographic pathology. Am J Roentgenol 1997; 169: 717-721
57. Tanswell P, Tebbe U, Neuhaus KL, Gläsle-Schwarz L, Wojcik J, Seifried E. Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction. J Am Coll Cardiol 1992; 19: 1071-1075
58. The GUSTO Angiographic Investigators: The effect of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-1622
59. The STILE Investigators: Results of a prospective randomized trial evaluating surgery versus thrombolytic for ischemia of the lower extremity. Ann Surg 1994; 220: 251-268
60. Tillett WS, Garner RL. The fibrinolytic activity of hemolytic streptococci. J Exp Med 1933; 68: 485-502
61. Topol E, Califf R. Thrombolytic therapy for elderly patients. N Engl J Med 1992; 327: 45-47
62. Valji K, Bookstein JJ, Roberts A, Sanchez R. Occluded peripheral arteries and bypass grafts: lytic stagnation as an end point for pulse-spray pharmacomechanical thrombolysis. Radiology 1993; 188: 389-394
63. van Breda A, Groar RA, Katzen BT, Risius B, Gillings D. Relative costeffectiveness of urokinase versus streptokinase in the treatment of peripheral vascular disease. JVIR1991; 2: 77-87
64. Wagner HJ, Starck E, Alfke H, Reuter P. Konventionelle lokale intraarterielle Fibrinolyse, Spraylyse und mechanisch akzelerierte Fibrinolyse: Standortbestimmung im Spektrum der Angioplastietechniken. Fortschr Röntgenstr 1993; 159: 466-470
65. Wagner HJ. Periphere arterielle Fibrinolyse und Thrombektomie. In: Günther RW. Thelen M (Hrsg.). Interventionelle Radiologie. Stuttgart: Thieme, 1996:195-205
66. Weitz JI. Limited fibrin specifity of tissue-type plasminogen activator and its potential link to bleeding. JVIR 1995; 6 (suppl.): 19-23
67. Wengrovitz M, Healy D, Gifford R, Atnip R, Thiele B. Thrombolytic therapy and ballon catheter thrombectomy in experimental femoral artery thrombosis: effect on arterial wall morphology. JVIR 1995; 6: 205-210
68. Yusuf S, Whitaker S, Gregson R, Wenham P, Hopkinson B, Makin G. Prospective randomised comparative study of pulse spray and conventional local thrombolysis. Eur J Vasc Surg 1995; 10: 136-141